Literature DB >> 24365351

Diabetic neuropathy.

Gerald Charnogursky1, Hong Lee2, Norma Lopez2.   

Abstract

Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors, we do not have effective medications to treat the pathophysiologic mechanisms of diabetic neuropathies. Treatment is limited to ameliorating pain and correcting the end organ consequences of the neuropathic processes.
© 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Peripheral neuropathy; autonomic neuropathy; diabetic complications; mononeuropathy; polyneuropathy

Mesh:

Year:  2014        PMID: 24365351     DOI: 10.1016/B978-0-7020-4087-0.00051-6

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  10 in total

1.  Ocular surface changes in type II diabetic patients with proliferative diabetic retinopathy.

Authors:  Yan Gao; Yan Zhang; Yu-Sha Ru; Xiao-Wu Wang; Ji-Zhong Yang; Chun-Hui Li; Hong-Xing Wang; Xiao-Rong Li; Bing Li
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 2.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

3.  G protein αq exerts expression level-dependent distinct signaling paradigms.

Authors:  Dinesh Kankanamge; Mithila Tennakoon; Amila Weerasinghe; Luis Cedeno-Rosario; Deborah N Chadee; Ajith Karunarathne
Journal:  Cell Signal       Date:  2019-03-05       Impact factor: 4.315

Review 4.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

Review 5.  Diabetes complications and extracellular vesicle therapy.

Authors:  Setareh Soltani; Kamran Mansouri; Shahram Parvaneh; Avnesh S Thakor; Flemming Pociot; Reza Yarani
Journal:  Rev Endocr Metab Disord       Date:  2021-10-14       Impact factor: 6.514

Review 6.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

7.  Sildenafil ameliorates long term peripheral neuropathy in type II diabetic mice.

Authors:  Lei Wang; Michael Chopp; Alexandra Szalad; LongFei Jia; XueRong Lu; Mei Lu; Li Zhang; Yi Zhang; RuiLan Zhang; Zheng Gang Zhang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

8.  Triphala Churna-A Traditional Formulation in Ayurveda Mitigates Diabetic Neuropathy in Rats.

Authors:  Sachin V Suryavanshi; Kalyani Barve; Veeranjaneyulu Addepalli; Sachin V Utpat; Yogesh A Kulkarni
Journal:  Front Pharmacol       Date:  2021-06-03       Impact factor: 5.810

9.  Niosomes of active Fumaria officinalis phytochemicals: antidiabetic, antineuropathic, anti-inflammatory, and possible mechanisms of action.

Authors:  Karim M Raafat; Sally A El-Zahaby
Journal:  Chin Med       Date:  2020-05-01       Impact factor: 5.455

Review 10.  Axonal Endoplasmic Reticulum Dynamics and Its Roles in Neurodegeneration.

Authors:  Zeynep Öztürk; Cahir J O'Kane; Juan José Pérez-Moreno
Journal:  Front Neurosci       Date:  2020-01-29       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.